Mr Bancel told the Financial Times: 'All the scientists I've talked to. The chief executive said they were particularly concerned by 32 mutations on the spike protein - which the virus uses to invade cells - which would likely lead to a 'material drop' in jab effectiveness. Stephane Bancel, who leads the vaccine manufacturer, said another two weeks were needed for scientists to work out how effective the current jabs are against the variant, but that early signs are not encouraging. The head of Moderna today warned it will take months to develop an Omicron-fighting vaccine as Boris Johnson prepared to hold a Downing Street press briefing - and Scotland confirmed three more cases.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |